Chief Executive got a chance to sit down and talk with former Aetna CEO Mark Bertolini on how CEOs can improve the cost of care and employee wellness at their own companies, how he got into yoga, why the CVS deal was the right move for Aetna and more.
Here's a look into a process for building value into companies and the role of a turnaround specialist in asset recovery and valuation preservation for troubled companies.
Ending a business partnership doesn’t have to be messy. If both parties are communicating and the reason for the separation is clear, there’s no reason why you can’t continue to provide value to each other throughout the transition.
Need to speed up your firm’s technology metabolism? Scared of a pricey acquisition? Here are some alternatives.
The availability of capital and appetite for both building scale and leveraging new tech capabilities remain substantial, and that should drive a healthy deals cadence in 2019.
Despite a track record of mixed performance, joint ventures remain top-of-mind for healthcare dealmakers.
While a good digital M&A playbook covers several key topics, valuation and integration are of particular importance.
The Justice Department approved the $69 billion CVS-Aetna merger. What will be the larger impact of vertical integration in healthcare?
Josh McCarter, the founder and CEO of Booker, talks about about selling the business to competitor Mindbody and why this was the best course of action.
In the age of Amazon, companies need to be intelligent, agile, automated and on the cloud. But building this kind of operation isn’t easy, and mergers, acquisitions and divestitures are becoming a strategic tool of choice for companies to buy their way into the model.